Remedy Robotics Partners with Mission Thrombectomy
Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leading clinician network dedicated to accelerating access to endovascular thrombectomy in stroke.
The partnership aims to expand access to thrombectomy in the U.S. and globally using the Remedy Robotics N1 system, a remotely operable endovascular robot that combines proprietary hardware and AI-enabled software.
- Expands access to thrombectomy in the U.S. and globally
- Utilizes the Remedy Robotics N1 system
- Follows a recent partnership with the Australian Stroke Alliance
The company touts N1 as the world’s first remotely operable endovascular robot.
Remedy Robotics unveiled the N1 system earlier this month, highlighting its potential for faster, safer, and more effective innovation in cardiovascular conditions.
Author's summary: Remedy Robotics partners with Mission Thrombectomy to expand thrombectomy access globally.
More News
- Action across the nation to ban greyhound racing
- How training ground reminders of Kelleher are inspiring LFC new signing
- Science Must Guide Policy on Protein Hydrolysate Biostimulants
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Government gridlock cannot shut down the American farmer
- Two years later, no closure for family of missing Ghanaian fisheries observer
- Ireland edge out Scotland in Hurling-Shinty international clash